SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001599298-21-000021
Filing Date
2021-05-17
Accepted
2021-05-17 16:12:10
Documents
3
Period of Report
2021-05-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K summittherapeuticsmarch2021.htm 8-K 20342
2 EX-99.1 pressreleaseq1-march2021.htm EX-99.1 111297
3 summitmasterrgbjpeg1a.jpg GRAPHIC 65667
  Complete submission text file 0001599298-21-000021.txt   223407
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 21930693
SIC: 2834 Pharmaceutical Preparations